Welcome to Idenix Pharmaceuticals
  • contact us
  • search
  • site map

Idenix Home

  • About Idenix
    • Overview
    • Executive Management
    • Board of Directors
    • Corporate Compliance & Governance
    • Careers
    • Locations
  • Antiviral Focus
    • About the Diseases
    • Idenix Antiviral Pipeline
    • Publications & Presentations
    • Clinical Trials
  • HCV
    • Innovation
    • Drug Discovery & Development
    • HCV Pipeline
    • Evolution of Treatment
    • Publications
    • Clinical Trials
  • Corporate Partners
    • Novartis
    • Janssen Pharmaceuticals Inc.
    • Business Development
  • Patient Support
    • Disease Information
    • Clinical Trials
    • Contact Idenix
  • Investor
    • Stock Information
    • Financial Highlights
    • SEC Filings
    • Corporate Compliance and Governance
    • News Releases
    • Media Kit
    • Events
    • Investor Presentations
    • Investor FAQ
    • Product Pipeline
    • Requests & Contacts

View Our Latest HCV Publications and Presentations

Follow @IdenixPharma

Stock Quote
IDIX
Stock Quote Investor information

June 10, 2013
Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors
Read more

June 6, 2013
Idenix Pharmaceuticals Announces Samatasvir (IDX719) Poster Presentations at the Asian Pacific Association for the Study of the Liver (APASL) Conference
Read more

 
terms of use      privacy policy